Core Scientific Reports Q3 Revenue of $81.1 Million and Net Loss of $146.7 Million

Reuters
2025/10/25
<a href="https://laohu8.com/S/CORZ">Core Scientific</a> Reports Q3 Revenue of $81.1 Million and Net Loss of $146.7 Million

Core Scientific Inc. reported total revenue of $81.1 million for the third quarter of 2025, down from $95.4 million in the same period of 2024. Digital asset self-mining revenue was $57.4 million, a decrease from $68.1 million last year, primarily due to a 55% reduction in bitcoin mined, partially offset by an 88% increase in the average bitcoin price. Digital asset hosted mining revenue declined to $8.7 million from $16.9 million. High-Density Colocation revenue rose to $15.0 million from $10.3 million in the prior year. Adjusted EBITDA was $(2.4) million, compared to $10.1 million in the third quarter of 2024. Capital expenditures reached $244.5 million, with $196.4 million funded by CoreWeave, Inc. Liquidity at the end of the quarter was $694.8 million, including $453.4 million in cash and cash equivalents and $241.4 million in bitcoin. Gross profit for the quarter was $3.9 million, compared to a gross loss of $0.2 million in the previous year. The net loss was $146.7 million, compared to $455.3 million in the prior-year period, mainly due to a lower GAAP non-cash fair value adjustment for outstanding warrants and contingent value rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251024934847) on October 24, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10